Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Axsome Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
AXSM
Nasdaq
8731
https://www.axsome.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Axsome Therapeutics Inc
30 Countries with the Lowest Depression Rates
- Mar 26th, 2024 10:24 am
20 Cloudiest Cities in the U.S., Ranked
- Mar 26th, 2024 8:56 am
Axsome Therapeutics Announces Results of CRESCENDO Narcolepsy Patient Survey Demonstrating Unmet Needs in Treated Narcolepsy Type 1 Patients
- Mar 25th, 2024 11:00 am
Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in the SYMPHONY Phase 3 Trial in Narcolepsy
- Mar 25th, 2024 10:30 am
Buying These Dirt-Cheap Stocks Could Be a Brilliant Move
- Mar 23rd, 2024 10:45 am
Axsome Triumphs Over Major Depressive Disorder With Auvelity
- Mar 22nd, 2024 2:00 pm
Axsome (AXSM) Begins Dosing in Depression Study on Sunosi
- Mar 20th, 2024 4:12 pm
Axsome Therapeutics Initiates PARADIGM Phase 3 Trial of Solriamfetol for the Treatment of Major Depressive Disorder
- Mar 19th, 2024 11:00 am
11 Oversold NASDAQ Stocks To Buy Right Now
- Mar 13th, 2024 7:32 pm
Axsome Therapeutics to Present at the Leerink Partners Global Biopharma Conference
- Mar 5th, 2024 12:00 pm
Axsome Therapeutics to Present at the TD Cowen 44th Annual Healthcare Conference
- Feb 27th, 2024 12:00 pm
3 Under-the-Radar Biotech Stocks With Upcoming Catalysts in 2024
- Feb 26th, 2024 8:04 pm
3 Biotech Stocks to Buy and Hold for the Next 10 Years
- Feb 26th, 2024 1:50 pm
Axsome (AXSM) Stock Falls Despite Q4 Earnings & Revenue Beat
- Feb 21st, 2024 3:39 pm
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q4 2023 Earnings Call Transcript
- Feb 21st, 2024 2:23 pm
Q4 2023 Axsome Therapeutics Inc Earnings Call
- Feb 21st, 2024 3:39 am
Axsome Therapeutics Inc (AXSM) Reports Robust Revenue Growth in Q4 and Full Year 2023
- Feb 20th, 2024 12:31 pm
Axsome Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Feb 20th, 2024 12:00 pm
Axsome Therapeutics (AXSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
- Feb 13th, 2024 3:00 pm
Breakeven On The Horizon For Axsome Therapeutics, Inc. (NASDAQ:AXSM)
- Feb 12th, 2024 12:50 pm
Scroll